MiMedx Group Inc (MDXG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $464.04M
Last updated: Nov 17, 2026 at 4:15 PM ET
MiMedx Group Inc (MDXG) Stock Chart
MiMedx Group (MDXG) has a latest price of $3.18 on Nov 17, 2026, 57.3% below its 52-week high of $7.45. Its price fell 56.9% over the past 12 months. The month-end price fell 56.5% over the 10 years through Oct 2026, a compound annual decline of 8.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $16.75 in Jan 2018 and its lowest $1.79 in Dec 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MDXG with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MDXG.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 28.5%, and over 6 months it fell 12.6%. The month-end price fell 40.9% over the 3 years through Oct 2026, a compound annual decline of 16.1%.
| Period | Change |
|---|---|
| 1 month | -27.4% |
| 3 months | -28.5% |
| 6 months | -12.6% |
| 12 months | -56.9% |
| 12 months, with dividends | -56.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -40.9% | -16.1% |
| 5 years | -43.4% | -10.7% |
| 10 years | -56.5% | -8.0% |
Price by Year
Its best calendar year was 2019, when the price rose 323.5%, and its weakest was 2018, when it fell 85.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.88 | -42.7% |
| 2025 | $6.77 | -29.6% |
| 2024 | $9.62 | +9.7% |
| 2023 | $8.77 | +215.5% |
| 2022 | $2.78 | -54.0% |
| 2021 | $6.04 | -33.5% |
| 2020 | $9.08 | +19.8% |
| 2019 | $7.58 | +323.5% |
| 2018 | $1.79 | -85.8% |
| 2017 | $12.61 | +42.3% |
Trading Range
The price is 24.2% below its 50-day average of $4.20 and 23.4% below its 200-day average of $4.15.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.18 | |
| 52-week high | $7.45 | -57.3% |
| 52-week low | $3.03 | +5.0% |
| 50-day average | $4.20 | -24.2% |
| 200-day average | $4.15 | -23.4% |
Price Risk
Over 3 years, its largest fall from a peak was 68.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.56 |
| Largest fall, 1 year | -57.4% |
| Largest fall, 3 years | -68.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MDXG
What is MDXG's 1-year price change?
MiMedx Group's price fell 56.9% over the past 12 months. With dividends included, the 12-month total return was -56.9%.
What is MDXG's 5-year price change?
MiMedx Group's month-end price fell 43.4% over the 5 years through Oct 2026, a compound annual decline of 10.7%. These figures leave out dividends.
What is MDXG's 52-week high and low?
MiMedx Group's 52-week high is $7.45 and its 52-week low is $3.03. Its latest price of $3.18 on Nov 17, 2026 is 57.3% below the high.
What is MDXG's beta?
MiMedx Group's 1-year beta against the S&P 500 is 0.56, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 57.4%.
Is the MDXG chart free?
Yes. Advanced Charting for MDXG is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MDXG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors